Company History

Adhezion's founders collaborated in advancing the clinical performance characteristics of cyanoacrylate adhesives

Efforts were focused in developing new technologies for improved performance

With numerous regulatory approvals, the company is strategically poised to engage in commercialization of it's proprietary technology

2001

Founders created Spartan Medial Products LLC
2002

Company establishes manufacturing and R&D facility in Hudson, NC.
2003

Company files for initial patents on proprietary technologies.
2007

Received approval for first 510K application & CE Mark.
2008

Sercured $5.25 million in series "A" Financing
SURGISEAL receives CE Mark approval
SURGISEAL Received FDA Market Clearance
FLORASEAL receives CE Mark approval
2009

FLORASEAL receives FDA Market Clearance
US & OUS Distribution established
2010

Secured $2.5 million in Series "B" Financing
2011

Secured $2.5M in financing & 2 major distribution agreements
2012

Secured $1 million in Series "A" Financing
2013

Brought on second largest U.S. hospital supplies distributor

Increased revenue by 75% over 2012 and increased net income threefold
2013

Brought on second largest U.S. hospital supplies distributor

Increased revenue by 75% over 2012 and increased net income threefold
Built new facility to vertically integrate packaging activities in Hudson, NC
Filed 11 patents and were issued 8
2016

Adhezion became the first and only company achieve an antibacterial claim for a Topical Skin Adhesive
2017

SecurePortIV Received FDA 510K Clearance
2018

Added SecurePortIV Catheter Securement Adhesive salesforce & Clinical Educators
2023

Adhezion Biomedical, LLC acquired by H.B. Fuller Group.